GENETIC JOURNAL
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero
For $249, Shouldn’t We All Have the Cancer Gene Panel?
Color Genomics just announced that for a mere $249 they are offering genetic testing for a panel of genes that will include BRCA1, BRCA2 and 17 other genes associated with cancer risk. Considering that the lead competitor in this space offers their cancer gene panel...
New Baby Gene Mapping Project Will Begin This Month
This month, doctors in Boston will being the BabySeq project, a trial program conducting whole genome sequencing on 240 healthy babies as well as 240 babies in intensive care. The team will look for genetic mutations that are strongly associated with diseases that...
You’ve Always Had the Power My Dear
Last week was a great reminder of the power of the consumer – namely, You. Forbes published an article about Angelina Jolie with which many of us in the hereditary cancer community took issue. Some felt the tone was a bit snarky and that the medical and scientific...
Discussion: Your Need-To-Know Guide To Colon Cancer
Updated March 5, 2019 In honor of March being Colorectal Cancer Awareness month, we've shared resources, information, and personal stories on prevention and living through cancer. We'd like to end the month with our attention on Lynch Syndrome – a hereditary cancer...
I Had a Cancer Gene Panel and All I Got Was This T-shirt
Over the past 15 years we’ve learned that there are many hereditary cancer genes that, when mutated, increase the risk of cancer development. Not just BRCA1 and BRCA2 for hereditary breast and ovarian cancer. Not just the Lynch Syndrome genes and APC for hereditary...
Angelina Jolie’s Op-Ed Sparks Wider Discussion About Hereditary Cancer
Following Angelina Jolie Pitt's disclosure earlier this week that she recently underwent a prophylactic bilateral salpingo-oophorectomy, we held an impromptu Tweet chat to discuss hereditary cancer and risk management. The BRCA community has certainly...
New Study Assesses Parent and Public Interest in Whole-Genome Sequencing
In a recent video, we outlined the pros and cons of whole exome sequencing in children and newborns, currently a controversial topic in the field of genetics. After all, there is still a lot that scientists and healthcare providers don't know about the...
Has the BRCA Monopoly Been Reborn?
A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time, at more than $4,000 a pop, in order to qualify for a new drug called...
Bringing Sexy Back After Cancer Diagnosis or Treatment
Last Updated: February 5, 2019 Have you lost that lovin’ feeling after a cancer diagnosis or treatment(s)? Or perhaps you haven’t been sexually active since having prophylactic removal of your breasts, colon, ovaries, uterus, or all of the above? Well, that’s not...